New hope for fighting Medication-Related weight gain
NCT ID NCT07342764
Summary
This study aims to find the best way to manage weight gain caused by antipsychotic medications used for schizophrenia. Researchers will compare three approaches over 26 weeks: adding the drug dapagliflozin, adding the drug metformin, or using lifestyle changes alone. The goal is to see which method helps people lose more weight and improves their overall health while they continue their necessary psychiatric treatment.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SCHIZOPHRENIA SPECTRUM AND OTHER PSYCHOTIC DISORDERS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
SQU
Muscat, Oman
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.